BioSpace News Archive

Business

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2022 Financial Results

Aligos Therapeutics, Inc. reported recent business progress and financial results for the first quarter March 31, 2022.

May 4, 2022
·
10 min read
Business

Axogen, Inc Reports 2022 First Quarter Financial Results

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, reported financial results and business highlights for the first quarter ended March 31, 2022.

May 4, 2022
·
15 min read
Business

Allogene Therapeutics Reports First Quarter 2022 Financial Results

Allogene Therapeutics, Inc. provided a corporate update and reported financial results for the quarter ended March 31, 2022.

May 4, 2022
·
9 min read
Business

Sarepta Therapeutics Announces First Quarter 2022 Financial Results and Recent Corporate Developments

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, reported financial results for the first quarter 2022.

May 4, 2022
·
28 min read
Business

OrthoPediatrics Corp. Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its financial results for the first quarter ended March 31, 2022.

May 4, 2022
·
15 min read
Drug Development

Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced topline results from its RECON Clinical Study comparing Avance Nerve Graft to conduits in digital nerve injuries.

May 4, 2022
·
7 min read
Business

Mirati Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Updates

Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, reported financial results for the first quarter of 2022 and recent corporate updates.

May 4, 2022
·
8 min read
Business

NuVasive Announces First Quarter 2022 Financial Results

NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced financial results for the quarter ended March 31, 2022.

May 4, 2022
·
20 min read
Biotech Bay

Jazz Pharmaceuticals and Sumitomo Pharma Announce Exclusive License Agreement to Develop and Commercialize DSP-0187, a Potent, Highly Selective Oral Orexin-2 Receptor Agonist

Jazz Pharmaceuticals plc and Sumitomo Pharma Co., Ltd. announced that the companies have entered into an exclusive licensing agreement under which Jazz has acquired development and commercialization rights in the United States, Europe and other territories for Sumitomo Pharma’s investigational DSP-0187.

May 4, 2022
·
8 min read
Business

Personalis Reports First Quarter 2022 Financial Results

Personalis, Inc., a leader in advanced genomics for precision oncology, reported financial results for the first quarter ended March 31, 2022.

May 4, 2022
·
8 min read